SCHEMBL420193

SCHEMBL420193

CNC(=O)CSC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23185124 0.83 LMNA (0.38)
SCHEMBL15945376 0.79 KMT2A (0.48)
SCHEMBL12092123 0.78
SCHEMBL23940295 0.78
SCHEMBL19415970 0.74
SCHEMBL20852576 0.74
SCHEMBL7594795 0.74
SCHEMBL8703324 0.74
SCHEMBL18324419 0.74
SCHEMBL11264137 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102194-A1 SUBSTITUTED PYRIMIDINES AND THEIR USE AS JNK MODULATORS F. Hoffmann-Roche AG (CH) 2009-09-23 EP claimed
WO-2008068171-A9 SUBSTITUTED PYRIMIDINES AND THEIR USE AS JNK MODULATORS HOFFMANN LA ROCHE (CH) 2009-07-16 WO claimed
WO-2008068171-A1 SUBSTITUTED PYRIMIDINES AND THEIR USE AS JNK MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2008-06-12 WO claimed
US-11873281-B2 Conjugates of cell binding molecules with cytotoxic agents HANGZHOU DAC BIOTECH CO., LTD. (CN) 2024-01-16 US disclosed
US-11834406-B2 Conjugates of cell binding molecules with cytotoxic agents HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-12-05 US disclosed
WO-2023180485-A1 ANTIBODY-CONJUGATES FOR TARGETING OF TUMOURS EXPRESSING TROP-2 SYNAFFIX B.V. (NL) 2023-09-28 WO disclosed
US-11767294-B2 Conjugates of cell binding molecules with cytotoxic agents HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-09-26 US disclosed
US-20230270876-A1 SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES NOVARTIS AG (CH) 2023-08-31 US disclosed
EP-3188764-B1 POLYMER AND CONTRAST AGENT FOR PHOTOACOUSTIC IMAGING INCLUDING THE POLYMER CANON KK (JP) 2023-08-23 EP disclosed
US-20230241241-A1 CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS HANGZHOU DAC BIOTECH CO., LTD. (CN) 2023-08-03 US disclosed
US-20230242586-A1 RAS INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-08-03 US disclosed
US-20080318917-A1 POLYETHYLENE GLYCOLATED SUPEROXIDE DISMUTASE MIMETICS GALERA THERAPEUTICS, LLC 2008-12-25 US disclosed
US-20080274052-A1 RADIOFLORINATION METHODS GE HEALTHCARE LIMITED (GB) 2008-11-06 US disclosed
US-7439309-B2 Silver halide photographic light-sensitive material, photographic emulsion, and mercapto group-containing polymer compound used for them FUJIFILM CORPORATION (JP) 2008-10-21 US disclosed
US-20080164211-A1 Mixed-Modal Anion-Exchanged Type Separation Material MERCK PATENT GMBH (DE) 2008-07-10 US disclosed
WO-2008079924-A1 IMMUNE RESPONSE MODIFIER COMPOSITIONS AND METHODS 3M INNOVATIVE PROPERTIES COMPANY (US) 2008-07-03 WO disclosed
US-20080064606-A1 Polypeptide immobilization THE UNIVERSITY OF CHICAGO 2008-03-13 US disclosed
WO-2007100634-A2 IMMUNE RESPONSE MODIFIER CONJUGATES 3M INNOVATIVE PROPERTIES COMPANY (US) 2007-09-07 WO disclosed
US-7172905-B2 Polypeptide immobilization THE UNIVERSITY OF CHICAGO (US) 2007-02-06 US disclosed
US-4313949-A Method of producing an inhibitory effect on blood platelet aggregation A. H. ROBINS COMPANY, INC. (US) 1982-02-02 US disclosed